483
Aurolife Pharma LLCFDA 483 - Aurolife Pharma LLC - August 26, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Aurolife Pharma LLC in Durham, NC, from August 22-26, 2022, revealed significant deficiencies in the firm's corrective and preventive action (CAPA) procedures. The company's CAPA process failed to ensure the effectiveness of actions taken and did not adequately consider their potential adverse effects on finished products. This indicates a moderate severity issue related to quality system controls.
Open in Dashboard
ID · a5413264-1418-4ddc-ae62-3dadbcc49db5